Page last updated: 2024-11-06

2-tyrosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Tyrosine is a synthetic analogue of the naturally occurring amino acid tyrosine. It is characterized by the presence of a hydroxyl group at the ortho position of the aromatic ring. 2-Tyrosine is a valuable intermediate in the synthesis of various pharmaceutical compounds, including tyrosine kinase inhibitors, which are used in the treatment of cancer. Research on 2-Tyrosine has focused on understanding its potential therapeutic effects and its ability to modulate tyrosine kinase activity. The compound has shown promising results in inhibiting the growth of cancer cells in vitro and in vivo studies. Its importance lies in its potential as a novel drug candidate for treating various diseases.'

2-tyrosine: RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

o-tyrosine : A racemate comprising equimolar amounts of D- and L-o-tyrosine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-hydroxyphenylalanine : A phenylalanine derivative that is phenylalanine carrying a hydroxy substituent at position 2 on the benzene ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID91482
CHEMBL ID107813
CHEBI ID89461
CHEBI ID91038
SCHEMBL ID13537519
SCHEMBL ID1249620
MeSH IDM0087533

Synonyms (67)

Synonym
ortho-tyrosine
2-tyrosine
NCIOPEN2_000342
S446106
nsc-72345
709-16-0
nsc72345
o-tyrosine
dl-3-(o-hydroxyphenyl)alanine
alanine, 3-(o-hydroxyphenyl)-, dl
o-tyrosine, dl-
2-hydroxyphenylalanine
einecs 219-134-8
dl-o-tyrosine
T-9035
dl-2-tyrosine
CHEMBL107813
chebi:89461
T0786
2370-61-8
2-amino-3-(2-hydroxyphenyl)propionic acid
2-amino-3-(2-hydroxyphenyl)propanoic acid
A837023
AKOS009157280
2-azanyl-3-(2-hydroxyphenyl)propanoic acid
A816856
unii-rt7v2wzn17
rt7v2wzn17 ,
nsc 72345
(+-)-o-tyrosine
FT-0675712
FT-0675713
phenylalanine, 2-hydroxy-
FT-0625498
AB01309
AB09421
AB21388
d,l-o-tyrosine
(+/-)-o-tyrosine
dl-2-hydroxyphenylalanine
2-hydroxy-dl-phenylalanine
AM83353
SCHEMBL13537519
CHEBI:91038
SCHEMBL1249620
2-hydroxyphenylalanine #
dl-phenylalanine, 2-hydroxy-
dl-3-(2-hydroxyphenyl)alanine
tyrosine, o-
mfcd00021725
dl-o-tyrosine, >=96.0% (nt)
2-hydroxy-phenylalanine
dl- o-tyrosine
3-(o-hydroxyphenyl)dl-alanine
oxyphenylalanin
dl-ortho-tyrosine
Q27163035
BS-16226
5-nitro-2-(3-methylpiperidin-1-yl)benzoicacid
2-amino-3-(2-hydroxyphenyl)propanoicacid
nsc 72345; ortho-tyrosine; o-dl-tyrosine; o-tyrosine
N12180
DTXSID90946504
CS-0030729
HY-107848
EN300-157704
Z1065645436

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The aim was to study dose-response correlation between inspiratory fraction of oxygen used for resuscitation and urinary markers of oxidative damage to DNA and amino acids."( Resuscitation of hypoxic newborn piglets with oxygen induces a dose-dependent increase in markers of oxidation.
Andresen, JH; Escrig, R; Saugstad, OD; Solberg, R; Vento, M, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
phenylalanine derivativeAn amino acid derivative resulting from reaction of alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of phenylalanine by a heteroatom. The definition normally excludes peptides containing phenylalanine residues.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID92626Percent inhibition of specific [3H]AMPA binding to Ionotropic glutamate receptor AMPA in rat brain membranes at compound concentration of 100 uM1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines.
AID25862Protolysis constant at an ionic strength of 0.1 M.1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (6.52)18.7374
1990's14 (30.43)18.2507
2000's16 (34.78)29.6817
2010's12 (26.09)24.3611
2020's1 (2.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 74.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index74.55 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index124.96 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (74.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (4.26%)5.53%
Reviews2 (4.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (91.49%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]